Start Your Risk-Free Trial

Teriflunomide — Discount Pricing

Teriflunomide is not confirmed for no-additional-cost pricing. Discount pricing may be available; confirm the price with the dispensing pharmacy.

Teriflunomide Pricing

Pricing typePrice
TheDrugClubDiscount pricing may be available
Typical Retail$427.00

Discount pricing may be available; confirm the price with the dispensing pharmacy.

About Teriflunomide

Teriflunomide is a prescription medication. Ask your doctor if Teriflunomide is right for you.

How to Check Teriflunomide Pricing

  1. Join TheDrugClub for $19.95/month
  2. Receive your member card by email
  3. Present your card at a participating pharmacy
  4. Check active-formulary eligibility or available discount pricing

Teriflunomide at Participating Pharmacies

Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.

Other medications in Neurological

About Teriflunomide

Teriflunomide is a vital medication for individuals managing relapsing forms of multiple sclerosis (MS). At TheDrugClub, we understand the importance of affordable access to critical treatments. Our members can receive teriflunomide with a $0 co-pay and the convenience of free home delivery, ensuring you get the care you need without financial burden.

Multiple sclerosis (MS) is a chronic, often debilitating disease that affects the brain, spinal cord, and optic nerves, which collectively form the central nervous system. In MS, the immune system mistakenly attacks the protective sheath (myelin) that covers nerve fibers, leading to communication problems between your brain and the rest of your body. This can result in a wide range of symptoms, including numbness, weakness, vision problems, and difficulty with coordination.

What Teriflunomide Treats

Teriflunomide, often known by its brand name Aubagio, is an oral medication specifically approved to treat relapsing forms of multiple sclerosis. This includes clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. By taking teriflunomide, patients can significantly reduce the frequency and severity of MS relapses, slow the progression of physical disability, and decrease the number of new or enlarging brain lesions observed on MRI scans.

How Teriflunomide Works

Teriflunomide is an immunomodulatory agent. It works by inhibiting an enzyme called dihydroorotate dehydrogenase, which is essential for the production of pyrimidines. Pyrimidines are crucial building blocks for DNA and RNA, and rapidly dividing cells, particularly certain immune cells (like T and B lymphocytes involved in the autoimmune attack in MS), rely heavily on this pathway. By blocking this enzyme, teriflunomide reduces the proliferation of these activated immune cells, effectively dampening the immune system's attack on the myelin sheath in the central nervous system. This helps to reduce inflammation and protect nerve cells from damage, thereby managing the progression of MS.

Understanding Typical Costs

Specialty medications like teriflunomide are often life-changing, but they also come with a significant price tag. Without adequate insurance coverage or assistance programs, the cost of teriflunomide can be prohibitive, often running into several thousand dollars per month. This substantial financial burden can be a major barrier to consistent treatment, impacting both the patient's health and their financial stability.

Get Teriflunomide for $0 Co-pay with

The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.

What Teriflunomide is approved for (FDA label)

Teriflunomide tablets are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. Teriflunomide is a pyrimidine synthesis inhibitor indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. ( 1 )

Source: Read the full FDA label on DailyMed. Label effective date: August 26, 2026.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Start Your Risk-Free Trial
Start Your Risk-Free Trial